Clinical Trial Update: Predictive Genetic Risk Assessment Trial

View source ↗

Summary

This Mayo Clinic-sponsored trial on Predictive Genetic Risk Assessment has completed, investigating genetic risk prediction across multiple conditions including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Breast Cancer
• Colorectal Cancer
• Graves Disease
• Lung Cancer
• Obesity
• Osteoarthritis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Colon Cancer, Lung Cancer | Status: COMPLETED